Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention.
Menter DG. Menter DG. Expert Opin Investig Drugs. 2002 Dec;11(12):1749-64. doi: 10.1517/13543784.11.12.1749. Expert Opin Investig Drugs. 2002. PMID: 12457435 Review.
Effect of cyclooxygenase inhibitors in the adhesion of tumor cells to endothelial cells.
Papadimitriou MN, McIntire LV, Menter DG. Papadimitriou MN, et al. Crit Rev Biomed Eng. 2000;28(1-2):193-4. doi: 10.1615/critrevbiomedeng.v28.i12.320. Crit Rev Biomed Eng. 2000. PMID: 10999385 No abstract available.
Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398.
Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang DG, Lippman SM. Xu XC, et al. Neoplasia. 2003 Mar-Apr;5(2):121-7. doi: 10.1016/s1476-5586(03)80003-9. Neoplasia. 2003. PMID: 12659684 Free PMC article.
Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells.
Yang P, Chan D, Felix E, Cartwright C, Menter DG, Madden T, Klein RD, Fischer SM, Newman RA. Yang P, et al. J Lipid Res. 2004 Jun;45(6):1030-9. doi: 10.1194/jlr.M300455-JLR200. Epub 2004 Mar 1. J Lipid Res. 2004. PMID: 14993240
Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells.
Subbarayan V, Sabichi AL, Kim J, Llansa N, Logothetis CJ, Lippman SM, Menter DG. Subbarayan V, et al. Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1710-6. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15533897
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products.
Kim J, Yang P, Suraokar M, Sabichi AL, Llansa ND, Mendoza G, Subbarayan V, Logothetis CJ, Newman RA, Lippman SM, Menter DG. Kim J, et al. Cancer Res. 2005 Jul 15;65(14):6189-98. doi: 10.1158/0008-5472.CAN-04-4439. Cancer Res. 2005. PMID: 16024620
Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward.
Menter DG, Schilsky RL, DuBois RN. Menter DG, et al. Clin Cancer Res. 2010 Mar 1;16(5):1384-90. doi: 10.1158/1078-0432.CCR-09-0788. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179228 Free PMC article. Review.
Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer.
Holla VR, Wu H, Shi Q, Menter DG, DuBois RN. Holla VR, et al. J Biol Chem. 2011 Aug 26;286(34):30003-9. doi: 10.1074/jbc.M110.184697. Epub 2011 Jul 10. J Biol Chem. 2011. PMID: 21757690 Free PMC article.
90 results
Jump to page
Feedback